PMID: 4116939Nov 11, 1972

Effect of cardiac glycosides on human cerebrospinal-fluid production

Lancet
C R NeblettG M Harrison

Abstract

No abstract listed.

Citations

Dec 1, 1973·British Medical Journal·E B Murphy
Nov 1, 1976·Postgraduate Medical Journal·G D SchottA M Hayler
Jul 1, 1988·Journal of Geriatric Psychiatry and Neurology·M St-Laurent
Feb 6, 2016·Fluids and Barriers of the CNS·Marc R Del Bigio, Domenico L Di Curzio
Apr 18, 2001·Journal of Clinical Pharmacology·J Hannerz
Apr 1, 1979·Clinical Cardiology·L StorsteinO Sjaastad
Sep 1, 1977·Acta Pharmacologica Et Toxicologica·H AllonenG Wettrell
Jan 1, 1978·Journal of Clinical Pharmacology·J M GayesT W Smith
Apr 1, 1983·Developmental Medicine and Child Neurology·E A LiechtyM J Bull
Apr 1, 1975·Acta Pharmacologica Et Toxicologica·J KantoT Siirtola
Nov 1, 1983·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J J Corbett
Apr 5, 2017·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·David I Kaufman, Deborah I Friedman

Related Concepts

Acetazolamide Sodium, (Sterile)
Cardiac Glycosides
Cerebrospinal Fluid
Cerebrospinal Fluid Shunts Procedure
Digitoxin-Philo
Mapluxin
Aqueductal Stenosis
Postoperative Complications
Relapse

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.